Cancer
p53 187-197 (HLA-A*02:01) GLAPPQHLIRV
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11379_1
Description
p53-derived peptide of GLAPPQHLIRV sequence covering 187-197 and HLA-A*02:01) molecule. The peptide p53 187-197 recognizes human CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. GLAPPQHLIRV is a linear peptidic epitope (epitope ID20767) studied as part of Cellular tumor antigen p53 from Homo sapiens (human) and Cellular tumor antigen p53 from Otospermophilus beecheyi (California ground squirrel). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
TechData
| Sequence: | GLAPPQHLIRV |
| Gene: | TP53 |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Cellular tumor antigen p53 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |